LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Legal & Regulatory and Reimbursement/CMS Increases SI Fusion Payment 27%
Legal & Regulatory and Reimbursement

CMS Increases SI Fusion Payment 27%

November 19, 2019 1 min read Premium comments

Advertisement

CMS Increases SI Fusion Payment 27%
Final Implant Placement + 3D-Implant Overlay / Courtesy of SI-BONE
#siboneSecondary#sijointfusion#ifuseimplantsystem#cms

Medical device company SI-BONE, Inc. has announced that the Centers for Medicare and Medicaid Services (CMS) has updated the fee schedule utilized in reporting minimally invasive sacroiliac (SI) joint fusion procedures.

Beginning on January 1, 2020, the Medicare Physician Fee Schedule for CPT® Code 27279 will increase the Work Relative Value Units (wRVUs) from 9.03 to 12.13.

The CPT code’s surgeon payment from Medicare will increase 27%, from $720 to $915. CMS arrived at this decision in part due to national surgeon reports and evidence that wRVUs regarding such procedures between the years 2015 and 2019. The reports indicated underestimated time as well as complexity of work required by physicians performing these procedures.

Santa Clara, California-based SI-BONE was founded in 2008 and specializes in musculoskeletal disorders of the sacropelvic region. The company pioneered minimally invasive sacroiliac (SI) joint fusion procedures and, today, is the market leader in this innovative procedure.

The iFuse Implant™ system has been in commercial use since 2009 and is indicated by the FDA for the treatment of conditions including sacroiliac joint dysfunction as a direct result of sacroiliac joint disruption and degenerative sacroiliitis. This includes incidents that develop as a result of pregnancy.

The system is also intended for use in sacroiliac fusion to support immobilization and stabilization of the sacroiliac joint in adult patients undergoing sacropelvic fixation during lumbar or thoracolumbar fusion.

Due to a body of over 75 peer-reviewed studies demonstrating safety, efficacy, affordability and the biomechanical benefits of the iFuse Implant, many private and government insurers cover SI joint fusion procedure exclusively when completed with the iFuse Implant System.

Jeffrey Dunn, president, CEO and chairman at SI-BONE stated, “Since the FDA clearance of iFuse, more than 40,000 procedures have been performed by 1,900 surgeons, helping patients with SI joint dysfunction experience significantly less pain and improved quality of life…We applaud this decision by CMS to increase the physician fee for CPT 27279 based on the greater work effort and intensity involved when performing these minimally invasive SI joint fusion procedures.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy